ONSTRYV 50 MG
SAFINAMIDE (SAFINAMIDE MESYLATE) : 50 MG · DIN 02484641 · VALEO PHARMA INC
Health Canada status: MARKETED
What is ONSTRYV?
ONSTRYV 50 MG contains SAFINAMIDE (SAFINAMIDE MESYLATE) : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02484641, held by VALEO PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 08-Jul-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ONSTRYV used for?
ONSTRYV (Safinamide tablets) is indicated as an add-on therapy to a regimen that includes levodopa for the treatment of the signs and symptoms of idiopathic Parkinson’s disease (PD) in patients experiencing “off” episodes while on a stable dose of levodopa (see Clinical Trials). ONSTRYV has not been shown to be effective as monotherapy for the treatment of PD.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02484641 |
|---|---|
| Brand name | ONSTRYV |
| Generic / active ingredient | SAFINAMIDE (SAFINAMIDE MESYLATE) : 50 MG |
| Manufacturer | VALEO PHARMA INC |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N04BD03 SAFINAMIDE |
| AHFS class | 28:36.32 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 08-Jul-2019 |
| Original market date | 2019-07-08 00:00:00 |
How is it stored and handled?
null
How is it supplied?
PVC/PVDC aluminium blister packs of 14 (sample) and 30 (trade size)
What can be used instead?
Other Canadian products sharing ATC code N04BD03 SAFINAMIDE. 2 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ONSTRYV | 100 MG | TABLET | VALEO PHARMA INC | MARKETED | DIN 02484668 |
Who else supplies SAFINAMIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SAFINAMIDE appears in 70 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.